HK1156077A1 - Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides - Google Patents

Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides

Info

Publication number
HK1156077A1
HK1156077A1 HK11110367.1A HK11110367A HK1156077A1 HK 1156077 A1 HK1156077 A1 HK 1156077A1 HK 11110367 A HK11110367 A HK 11110367A HK 1156077 A1 HK1156077 A1 HK 1156077A1
Authority
HK
Hong Kong
Prior art keywords
urlc10
lung cancers
peptide vaccines
cancers expressing
expressing ttk
Prior art date
Application number
HK11110367.1A
Other languages
English (en)
Inventor
Takuya Tsunoda
Hideaki Tahara
Shuichi Nakatsuru
Yataro Daigo
Yusuke Nakamura
Original Assignee
Oncotherapy Science Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncotherapy Science Inc filed Critical Oncotherapy Science Inc
Publication of HK1156077A1 publication Critical patent/HK1156077A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK11110367.1A 2005-02-25 2011-09-30 Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides HK1156077A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65685705P 2005-02-25 2005-02-25

Publications (1)

Publication Number Publication Date
HK1156077A1 true HK1156077A1 (en) 2012-06-01

Family

ID=36570330

Family Applications (2)

Application Number Title Priority Date Filing Date
HK11110367.1A HK1156077A1 (en) 2005-02-25 2011-09-30 Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
HK11110363.5A HK1156076A1 (en) 2005-02-25 2011-09-30 Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK11110363.5A HK1156076A1 (en) 2005-02-25 2011-09-30 Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides

Country Status (10)

Country Link
US (2) US7847060B2 (es)
EP (3) EP2325305B1 (es)
JP (5) JP4461179B2 (es)
DE (1) DE602006021283D1 (es)
DK (2) DK2325306T3 (es)
ES (3) ES2459466T3 (es)
HK (2) HK1156077A1 (es)
PL (2) PL2325305T3 (es)
PT (2) PT2325305E (es)
WO (1) WO2006090810A2 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200413725A (en) * 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
EP2468887A1 (en) * 2006-12-13 2012-06-27 Oncotherapy Science, Inc. TTK as tumor marker and therapeutic target for lung cancer
TWI596109B (zh) * 2007-02-21 2017-08-21 腫瘤療法 科學股份有限公司 表現腫瘤相關抗原之癌症的胜肽疫苗
AU2012261723B2 (en) * 2007-02-21 2014-11-27 Oncotherapy Science, Inc. Peptide vaccines for cancers expressing tumor-associated antigens
JP2010535014A (ja) * 2007-07-30 2010-11-18 オンコセラピー・サイエンス株式会社 癌関連遺伝子ｌｙ６ｋ
RU2483078C2 (ru) 2007-08-20 2013-05-27 Онкотерапи Сайенс, Инк. Cdh3-пептид и включающее его лекарственное средство
TWI543767B (zh) * 2008-08-19 2016-08-01 腫瘤療法 科學股份有限公司 Ｈｉｇ２與ｕｒｌｃ１０抗原決定位胜肽以及含此胜肽之疫苗
TW201008574A (en) 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same
SG195571A1 (en) 2008-10-22 2013-12-30 Oncotherapy Science Inc Rab6kifl/kif20a epitope peptide and vaccines containing the same
TWI500932B (zh) 2008-12-05 2015-09-21 Oncotherapy Science Inc Ｗｄｒｐｕｈ抗原決定位胜肽以及含此胜肽之疫苗
CA2747686A1 (en) 2008-12-24 2010-07-01 Oncotherapy Science, Inc. C1orf59 peptides and vaccines including the same
MX2011008917A (es) * 2009-03-04 2011-09-09 Oncotherapy Science Inc Peptidos vangl1 y vacunas que incluyen los mismos.
TW201100090A (en) * 2009-04-01 2011-01-01 Oncotherapy Science Inc C6orf167 peptides and vaccines containing the same
TW201102081A (en) * 2009-05-11 2011-01-16 Oncotherapy Science Inc TTK peptides and vaccines including the same
PT2474315T (pt) * 2009-09-03 2018-03-15 Toray Industries Indutor de imunidade
TW201124530A (en) * 2009-12-01 2011-07-16 Oncotherapy Science Inc IMP-3 oligopeptides and vaccines including the same
TW201200525A (en) * 2009-12-04 2012-01-01 Oncotherapy Science Inc MYBL2 peptides and vaccines containing the same
WO2012032763A1 (en) * 2010-09-07 2012-03-15 Oncotherapy Science, Inc. Vangl1 peptides and vaccines including the same
KR20140138900A (ko) * 2012-03-09 2014-12-04 온코세라피 사이언스 가부시키가이샤 펩티드를 포함한 의약 조성물
EP2872531A4 (en) * 2012-07-10 2016-04-06 Oncotherapy Science Inc LY6K EPITOPE PEPTIDES FOR TH1 CELLS AND VACCINES CONTAINING SAME
TWI643867B (zh) 2013-05-24 2018-12-11 日商腫瘤療法 科學股份有限公司 對於ｔｈ１細胞之ｉｍｐ－３抗原決定位胜肽及含此之疫苗
BR112017002206A2 (pt) 2014-08-04 2017-11-21 Oncotherapy Science Inc peptídeo derivado de koc1 e vacina incluindo o mesmo
AU2015300260B2 (en) 2014-08-04 2020-01-02 Oncotherapy Science, Inc. URLC10-derived peptide and vaccine containing same
WO2016080367A1 (ja) * 2014-11-18 2016-05-26 塩野義製薬株式会社 安定化されたペプチド組成物
WO2021060343A1 (ja) * 2019-09-24 2021-04-01 オンコセラピー・サイエンス株式会社 Ｕｒｌｃ１０由来ペプチドまたはｄｅｐｄｃ１由来ペプチドを認識するヒトｔ細胞が発現するｔ細胞受容体

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722848A (en) 1982-12-08 1988-02-02 Health Research, Incorporated Method for immunizing animals with synthetically modified vaccinia virus
US5703055A (en) 1989-03-21 1997-12-30 Wisconsin Alumni Research Foundation Generation of antibodies through lipid mediated DNA delivery
US5804566A (en) 1993-08-26 1998-09-08 The Regents Of The University Of California Methods and devices for immunizing a host through administration of naked polynucleotides with encode allergenic peptides
US5679647A (en) 1993-08-26 1997-10-21 The Regents Of The University Of California Methods and devices for immunizing a host against tumor-associated antigens through administration of naked polynucleotides which encode tumor-associated antigenic peptides
US5739118A (en) 1994-04-01 1998-04-14 Apollon, Inc. Compositions and methods for delivery of genetic material
US5736524A (en) 1994-11-14 1998-04-07 Merck & Co.,. Inc. Polynucleotide tuberculosis vaccine
US5922687A (en) 1995-05-04 1999-07-13 Board Of Trustees Of The Leland Stanford Junior University Intracellular delivery of nucleic acids using pressure
EP0841945B1 (en) 1995-08-03 2006-03-08 Rijksuniversiteit te Leiden Cell derived antigen presenting vesicles
US5853719A (en) 1996-04-30 1998-12-29 Duke University Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
US6294378B1 (en) 1996-07-26 2001-09-25 Sloan-Kettering Institute For Cancer Research Method and reagents for genetic immunization
WO1998045428A1 (de) 1997-04-07 1998-10-15 Roche Diagnostics Gmbh Fanconi-gen ii
DE59803082D1 (en) 1997-04-07 2002-03-21 Roche Diagnostics Gmbh Fanconi-gen ii
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
US6255055B1 (en) 1998-03-09 2001-07-03 Wisconsin Alumni Research Foundation c-myc coding region determinant-binding protein (CRD-BP) and its nucleic acid sequence
US20030236209A1 (en) 1998-03-18 2003-12-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
US20030045491A1 (en) 2001-02-23 2003-03-06 Christoph Reinhard TTK in diagnosis and as a therapeutic target in cancer
US20020119156A1 (en) 2000-03-29 2002-08-29 Sei-Yu Chen Compositions and methods of diagnosing, monitoring, staging, imaging and treating lung cancer
MXPA03003151A (es) 2000-10-13 2003-08-19 Eos Biotechnology Inc Metodos de diagnostico de cancer de prostata, composiciones y metodos para seleccionar moduladores de cancer de prostata.
AU2002220265A1 (en) * 2000-11-03 2002-05-15 University Of Vermont And State Agricultural College Compositions for inhibiting grb7
WO2002068444A1 (en) * 2001-02-21 2002-09-06 Chiron Corporation Ttk in diagnosis and as a therapeutic target in cancer
EP1463928A2 (en) 2001-04-18 2004-10-06 Protein Design Labs Methods of diagnosis of lung cancer, compositions and methods of screening for modulators of lung cancer
US7189507B2 (en) * 2001-06-18 2007-03-13 Pdl Biopharma, Inc. Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
MXPA04003382A (es) 2001-10-31 2004-11-22 Pfizer Prod Inc Agentes terapeuticos y diagnostico para transtornos de la eritropoyesis.
US20030232350A1 (en) * 2001-11-13 2003-12-18 Eos Biotechnology, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
WO2003042661A2 (en) 2001-11-13 2003-05-22 Protein Design Labs, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
EP1497454A2 (en) 2001-11-13 2005-01-19 Protein Design Labs, Inc. Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
EP1534739A4 (en) 2002-01-18 2006-05-31 Bristol Myers Squibb Co IDENTIFICATION OF POLYNUCLEOTIDES AND POLYPEPTIDES FOR PREDICTING THE ACTIVITY OF COMPOUNDS THAT INTERACT WITH TYROSINE KINASE PROTEINS AND / OR TYROSINE KINASE PROTEIN PATHWAYS
CN101613405A (zh) * 2002-06-06 2009-12-30 肿瘤疗法科学股份有限公司 与人结肠癌相关的基因和多肽
CN103951745A (zh) * 2002-09-12 2014-07-30 肿瘤疗法科学股份有限公司 Kdr肽和包括该肽的疫苗
US20060024692A1 (en) 2002-09-30 2006-02-02 Oncotherapy Science, Inc. Method for diagnosing non-small cell lung cancers
TW200413725A (en) 2002-09-30 2004-08-01 Oncotherapy Science Inc Method for diagnosing non-small cell lung cancers
ATE505538T1 (de) 2003-06-09 2011-04-15 Corixa Corp Dna-vektoren
JP4721903B2 (ja) * 2004-01-29 2011-07-13 大日本住友製薬株式会社 新規腫瘍抗原蛋白質及びその利用
JP2005230011A (ja) 2004-02-20 2005-09-02 Samsung Electronics Co Ltd 乳ガン関連蛋白質、それをコーディングする遺伝子、及び該蛋白質及び該遺伝子を利用した乳ガンの診断方法
ATE496142T1 (de) * 2004-03-23 2011-02-15 Oncotherapy Science Inc Verfahren zur diagnose von nicht-kleinzelligem lungenkrebs
EP1854473A1 (en) 2005-03-03 2007-11-14 Takeda Pharmaceutical Company Limited Preventive/therapeutic agent for cancer
EP2468887A1 (en) * 2006-12-13 2012-06-27 Oncotherapy Science, Inc. TTK as tumor marker and therapeutic target for lung cancer
JP2010535014A (ja) * 2007-07-30 2010-11-18 オンコセラピー・サイエンス株式会社 癌関連遺伝子ｌｙ６ｋ
TW201008574A (en) * 2008-08-19 2010-03-01 Oncotherapy Science Inc INHBB epitope peptides and vaccines containing the same

Also Published As

Publication number Publication date
DK2325305T3 (en) 2014-03-03
PL2325305T3 (pl) 2014-07-31
PL2325306T3 (pl) 2014-07-31
JP2008530975A (ja) 2008-08-14
JP4493053B2 (ja) 2010-06-30
DE602006021283D1 (de) 2011-05-26
US20090202576A1 (en) 2009-08-13
EP2325305A1 (en) 2011-05-25
ES2364670T3 (es) 2011-09-12
EP1853703B1 (en) 2011-04-13
ES2459492T3 (es) 2014-05-09
PT2325306E (pt) 2014-04-29
ES2459466T3 (es) 2014-05-09
EP2325306B1 (en) 2014-02-12
EP1853703A2 (en) 2007-11-14
JP4493054B2 (ja) 2010-06-30
EP2325306A1 (en) 2011-05-25
JP2009173662A (ja) 2009-08-06
WO2006090810A3 (en) 2007-03-29
JP2009173661A (ja) 2009-08-06
US7847060B2 (en) 2010-12-07
DK2325306T3 (en) 2014-03-03
HK1156076A1 (en) 2012-06-01
US8614176B2 (en) 2013-12-24
PT2325305E (pt) 2014-04-29
US20110027302A1 (en) 2011-02-03
JP4461179B2 (ja) 2010-05-12
EP2325305B1 (en) 2014-02-12
JP2010143924A (ja) 2010-07-01
WO2006090810A2 (en) 2006-08-31
JP2009173660A (ja) 2009-08-06

Similar Documents

Publication Publication Date Title
HK1156076A1 (en) Peptide vaccines for lung cancers expressing ttk, urlc10 or koc1 polypeptides
HK1171026A1 (en) Peptide vaccines for cancers expressing depdc1 polypeptides depdc1
GB0524788D0 (en) Polypeptides
EG25313A (en) Improved dry powder inhaler.
GB0520794D0 (en) Inhaler
IL186698A0 (en) Breath actuated inhaler
GB0519151D0 (en) Inhaler
GB0518355D0 (en) An inhaler
EP1859828A4 (en) INHALER
GB0508863D0 (en) Peptide
EP1735335A4 (en) Cell-destroying peptides
IL186880A0 (en) Evolved interferon alpha polypeptides
EP1765392A4 (en) POLYPETPIDES INDUCING APOPTOSIS
GB0524194D0 (en) Respirable powders
IL196292A0 (en) Csf3r polypeptides, their preparation and uses thereof
GB0505949D0 (en) Polypeptides
GB0526120D0 (en) Therapeutic peptides
GB0526019D0 (en) Peptides
GB0516527D0 (en) Peptides
GB0510091D0 (en) Inhaler
EP1881843A4 (en) KINASEPEPTIDES AND ANTIBODIES
GB0511861D0 (en) Proteins
ATE505536T1 (de) Peptid-impfstoff für lungenkrebs, der ttk polypeptide exprimiert
GB0508866D0 (en) Soluble polypeptide
GB0504769D0 (en) Polypeptides

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230217